A selection of data on the Nordic pharma markets (Denmark, Finland, Iceland, Norway, and Sweden), including market value, R&D spend, production, exports and imports, employment, generics penetration, and healthcare spending based on 2020 data from the EFPIA.
Sweden is the largest pharma market in the region, boasting a market value of EUR 4.137 billion.
The Danish pharma industry is the region’s biggest R&D spender, with EUR 1.629 billion invested in 2018.
Denmark is also the region’s largest pharma producer, with EUR 14.391 billion in production value for 2018.
Sweden and Denmark are the region’s largest exporters and importers of pharmaceuticals.
Denmark is by far the Nordics’ leading nation in terms of pharma industry employment, its total of 24,875 workers more than that of all the other countries’ in the region put together.
Generics penetration in the Nordics. Denmark has the largest share of generic medicines as part of total pharma market value with 32.6 percent.
Sweden, Denmark and Norway all spend between ten and 11 percent of their GDP on healthcare.